ArticleDiabetes, obesity & metabolism2026

Use of Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study.

Arvid Engström et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.